Lead Product(s) : Disodium Pamidronate Pentahydrate
Therapeutic Area : Immunology
Study Phase : Phase IV
Sponsor : Janssen-Cilag
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Pamidronate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Spondylitis, Ankylosing.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 10, 2014
Lead Product(s) : Disodium Pamidronate Pentahydrate
Therapeutic Area : Immunology
Highest Development Status : Phase IV
Sponsor : Janssen-Cilag
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Disodium Pamidronate Pentahydrate
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase II
Sponsor : INSERM CIC 501
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Pamidronate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Intervertebral Disc Degeneration.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 27, 2013
Lead Product(s) : Disodium Pamidronate Pentahydrate
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II
Sponsor : INSERM CIC 501
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
